Y. Minemoto et al., Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53, EXP CELL RE, 262(1), 2001, pp. 37-48
We investigated the effect of Adriamycin on FL-amnion (FL) cells, After tre
atment with the drug, the cells arrested at G2, but we did not detect an in
crease in the p21 levels. We established a p53-deficient derivative of thes
e cells, in which G2 arrest also occurred after treatment with Adriamycin,
suggesting that the arrest we observed in these cells is independent of the
p53 pathway. Low doses of Adriamycin (100-200 ng/ml) induced G2 arrest, wh
ile late S-phase arrest was observed at high doses (500-1000 ng/ml) in both
FL and p53-deficient FL cells, Accumulation of cyclin B1 was detected only
in cells arrested at G2, and not in those arrested at S phase, suggesting
that the S-phase checkpoint functioned efficiently even in p53-deficient FL
cells. In both cell lines, caffeine-induced activation of CDCS kinase was
detected only in cells arrested at G2 and CDC2 kinase-activated cells died
exhibiting features of apoptosis, CDCS kinase activation was inhibited by c
ycloheximide. Furthermore, cycloheximide inhibited activation of CDK2:cycli
n A, which normally precedes CDC2 kinase activation in caffeine-treated cel
ls. These results suggest that p53 and p21 do not have special roles in the
S- and G2-phase checkpoints and that CDK2:cyclin A could be the target of
the G2-phase DNA damage checkpoint. (C) 2001 Academic Press.